Persistence Market Research

Cardiac Surgery Devices Market Highlights Various Opportunities 2026

North America is the largest market for cardiac surgery devices and is expected to dominate the market throughout the forecast period. Asia Pacific is the fastest growing region in the forecast period.

 

Albany, NY -- (SBWIRE) -- 05/31/2018 -- Cardiac surgery is performed by heart surgeons due to complications in the heart or heart diseases like correct congenital heart disease, valvular heart disease, ischemic heart disease. Typically, neurological damage is the major concerned while doing the cardiac surgery. Patients who are at risk, stroke is higher and occurs generally 2-3% of people having cardiac surgery. Open heart surgery is performed in the internal structure of the heart when the patient's heart is open. There are different types of heart surgeries like endoscopic surgery; where a surgeon uses a camera and a specific endoscopic tools to complete the surgery, open heart surgery – in which the heart is stopped temporarily and a machine pump the blood and oxygen for a patient.

Another form of heart surgery which is gaining popularity is robot assisted heart surgery. It is a machine which performs surgery by the control of heart surgeons. The biggest advantage is the size of the incision made in the patient. Also, there is pediatric heart surgery – surgery for children and modern beating heart surgery which is an off-pump coronary artery bypass done by using a technique called endoscopic vessel harvesting (EVH).

Cardiac Surgery Devices Market: Drivers & Restraints

Rising emergence of cardiovascular diseases, increasing number of heart attacks and strokes, rising demand of minimally invasive procedures, increase spending per capita income, are key driving factor for this market. Furthermore, increasing elderly population, unhealthy and stressful lifestyle of consumers, obesity-related issues, technology advancement and innovation, are some other key driving factors in cardiac surgery market. Furthermore, all the above mentioned factors has led to increase in demand of cardiac surgery market in developed and developing regions.

Request a Toc of the Report @ https://www.persistencemarketresearch.com/toc/11002

With so many advantages and splendid features of cardiac surgery devices, it has few disadvantages too. High investment cost and shortage of professional/skilled surgeons are acting as a barrier for cardiac surgery market.

Cardiac Surgery Devices Market: Segmentation

Cardiac Surgery Devices Market is broadly classified on the basis of the following segments –

By Product Type :

Beating Heart Surgery Systems
Perfusion Disposables
Cardiac Ablation Devices
Cardiopulmonary Bypass Equipment

By End User:

Hospitals
Private
Public
Others Facilities (Defense Hospitals, Medical Colleges)

Cardiac Surgery Devices Market: Overview

The cardiac surgery devices market has grown substantially at a healthy CAGR due to increasing number cardiovascular disease. With rapid technological advancement and innovation, cardiac surgery devices market is expected to grow globally. North America is the largest market for cardiac surgery devices and Asia Pacific would be the fastest growing market in the forecast period.

Cardiac Surgery Devices Market: Region-wise Outlook

The cardiac surgery devices market is expected to register a double-digit CAGR over the forecast period. Depending on geographic regions, cardiac surgery devices market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, and Asia Pacific excluding Japan (APEJ), Japan, and Middle East & Africa (MEA).

Request a Brochure of the Report @ https://www.persistencemarketresearch.com/samples/11002

Cardiac Surgery Devices Market: Key Players

Some of the key market players for cardiac surgery devices market are Boston Scientific Corporation, Abbott Laboratories, AngioDynamics, COOK Medical, C. R. Bard, Inc., Terumo Cardiovascular Systems Corporation, St. Jude Medical, Inc., Thoratec Corporation, Edwards Lifesciences Corporation., TransMedics, Inc.